NO20005426L - Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer - Google Patents

Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer

Info

Publication number
NO20005426L
NO20005426L NO20005426A NO20005426A NO20005426L NO 20005426 L NO20005426 L NO 20005426L NO 20005426 A NO20005426 A NO 20005426A NO 20005426 A NO20005426 A NO 20005426A NO 20005426 L NO20005426 L NO 20005426L
Authority
NO
Norway
Prior art keywords
pellets
lipid
lowering agent
polymer
core coated
Prior art date
Application number
NO20005426A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005426D0 (no
Inventor
Valentin Florent Victor Conde
Paul Marie Victor Gilis
Peter Putteman
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20005426L publication Critical patent/NO20005426L/no
Publication of NO20005426D0 publication Critical patent/NO20005426D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005426A 1998-04-27 2000-10-27 Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer NO20005426D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201331 1998-04-27
PCT/EP1999/002768 WO1999055313A1 (fr) 1998-04-27 1999-04-20 Comprimes comportant un noyau enrobe par un agent reducteur de lipides et par un polymere

Publications (2)

Publication Number Publication Date
NO20005426L true NO20005426L (no) 2000-10-27
NO20005426D0 NO20005426D0 (no) 2000-10-27

Family

ID=8233644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005426A NO20005426D0 (no) 1998-04-27 2000-10-27 Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer

Country Status (14)

Country Link
EP (1) EP1073424A1 (fr)
JP (1) JP2002544118A (fr)
KR (1) KR20010041460A (fr)
CN (1) CN1308523A (fr)
AU (1) AU3710099A (fr)
BG (1) BG104757A (fr)
BR (1) BR9909963A (fr)
CA (1) CA2328970A1 (fr)
EE (1) EE200000796A (fr)
HU (1) HUP0102052A3 (fr)
NO (1) NO20005426D0 (fr)
PL (1) PL358909A1 (fr)
SK (1) SK15252000A3 (fr)
WO (1) WO1999055313A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1413624B1 (fr) * 2002-10-22 2006-03-08 Rohm and Haas Company Composition d'enrobage de comprimés
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US20080234291A1 (en) * 2004-01-21 2008-09-25 Marc Karel Jozef Francois Mitratapide Oral Solution
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
WO2019226213A2 (fr) 2018-03-08 2019-11-28 Incyte Corporation Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y
WO2020010003A1 (fr) 2018-07-02 2020-01-09 Incyte Corporation DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013499A1 (fr) * 1994-10-27 1996-05-09 Janssen Pharmaceutica N.V. Inhibiteurs de synthese d'apolipoproteines-b

Also Published As

Publication number Publication date
CA2328970A1 (fr) 1999-11-04
PL358909A1 (en) 2004-08-23
BG104757A (en) 2001-05-31
AU3710099A (en) 1999-11-16
EP1073424A1 (fr) 2001-02-07
SK15252000A3 (sk) 2001-10-08
NO20005426D0 (no) 2000-10-27
KR20010041460A (ko) 2001-05-25
WO1999055313A1 (fr) 1999-11-04
HUP0102052A2 (hu) 2002-05-29
JP2002544118A (ja) 2002-12-24
CN1308523A (zh) 2001-08-15
BR9909963A (pt) 2000-12-26
EE200000796A (et) 2002-06-17
HUP0102052A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
CA2269501A1 (fr) Comprimes a noyau enrobe d'un agent antifongique et d'un polymere
TW376322B (en) Beads having a core coated with an antifungal and a polymer
CA2315110A1 (fr) Granules a noyau enrobe d'un antifongique et d'un polymere
FI964249A (fi) Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti
WO2002072034A3 (fr) Formes pharmaceutiques chronotherapeutiques
ATE260642T1 (de) Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
BR0006227B1 (pt) composição sensìvel à radiação, uso de um composto de sal de diariliodÈnio, método para polimerização, substrato revestido, método para a produção de imagens, fotorresistor e composto de sal de diariliodÈnio.
NO20005426L (no) Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer
CA2350246A1 (fr) Administration regulee d'agents actifs
WO2005027843A3 (fr) Formes de dosage chronotherapeutique
BR9813901B1 (pt) composiÇço de revestimento e mÉtodo para prover um substrato com um sistema de revestimento em multi-camadas.
NO972880L (no) Utleveringsanordning for legemiddelsuspensjon med regulert frigivelse
HK1039054A1 (en) Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug.
AU8356298A (en) Projection exposure method, projection aligner, and methods of manufacturing andoptically cleaning the aligner
AU2940200A (en) Hydrophilic member, method for preparation thereof, and coating agent and apparatus for preparation thereof
AU5655296A (en) Electrostatic coating
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
NZ512683A (en) Taste-masked pharmaceutical particles that are suitable for making chewable tablets
DE69832092D1 (de) VERBESSERTE HMG CoA REDUKTASE-INHIBITOR FORMULIERUNG MIT VERLÄNGERTER FREISETZUNG
NO983145L (no) Materiale med substans beskyttet av deformerbare avstandsholdere, og fremgangsmÕte for dets fremstilling
ATE268593T1 (de) Bupropionhydrochlorid enthaltende tabletten mit gesteuerter wirkstoffabgabe
WO2002024174A3 (fr) Composition a liberation prolongee contenant de la clarithromycine
ES8308724A1 (es) Procediento para la fabricacion de un articulo solido coloreado portador al memos de una talla en resalte o sebresaliente
AU4358400A (en) Enzyme composite particles having an acidic barrier and a physical barrier coating
EP1068867A3 (fr) Comprimé pharmaceutique renfermant un AINS et misoprostol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application